Frontlight ResearchEarly access
Trial site
Eberhard Karls Universitaet Tuebingen
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Melanoma3 trials
- Atopic dermatitis (eczema)2 trials
- IgA nephropathy2 trials
- Psoriasis2 trials
- Psoriatic arthritis2 trials
- Brain metastases1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Macular degeneration1 trial
- Myeloproliferative neoplasms1 trial
- and 1 more
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- Janssen Research & Development, LLC2 trials
- ADARx Pharmaceuticals, Inc.1 trial
- Charite Universitaetsmedizin Berlin KöR1 trial
- Galderma R&D1 trial
- and 5 more
Running trials
Not yet recruiting
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration1 recruiting
- Melanoma1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026